Home › Funds › Royce & Associates › RLAY
Royce & Associates position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q2 2024)48.38K sh
Reported value held$315.44K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 32.02K | $352.60K | New |
| Q1 2024 | 14.22K | $118.04K | Reduce |
| Q2 2024 | 48.38K | $315.44K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026